CLASS II Device recall · Reported 26 Dec 2018 · FDA Enforcement Report

GloCyte RBC Reagent recalled by Advanced Instruments

Advanced Instruments is recalling GloCyte RBC Reagent, distributed nationwide in the US. The recall was initiated on 7 Feb 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart number 111011, Lot # R1513

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0640-2019
FDA event ID
79584
Recalling firm
Advanced Instruments, Norwood, MA
Classification
Class II
Status
Terminated
Recall initiated
7 Feb 2018
FDA classified
19 Dec 2018
Reported
26 Dec 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Device type
Spinal Implants

Timeline

7 Feb 2018Recall initiated by company
19 Dec 2018Classified by FDA+315 days
26 Dec 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

RBC Reagent failure. High fluorescent counts during RBC Reagent + Diluent QC check that will result in failed QC check, preventing user from testing patient samples for RBC.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

GloCyte RBC Reagent - Product Usage: The GloCyte Automated Cell Counter System is intended for use by trained healthcare professionals in clinical laboratories to provide quantitative determination of fluorescence labeled total nucleated cells and erythrocytes in cerebrospinal fluid collected from adult and pediatric patients. The GloCyte Low and High Level Controls are assayed hematology controls designed to monitor the performance of the GloCyte Automated Cell Counter System. Assayed parameters include total nucleated cells and erythrocytes.

Where it was distributed

US Nationwide distribution in the states of IN, WA, NC, CA, GA, CO.

Nationwide CaliforniaColoradoGeorgiaNorth CarolinaWashington

Questions about this recall

Is GloCyte RBC Reagent recalled?

Yes. Advanced Instruments recalled GloCyte RBC Reagent on 7 Feb 2018. The recall is Class II and its status is Terminated. Recall number Z-0640-2019.

Why was it recalled?

RBC Reagent failure. High fluorescent counts during RBC Reagent + Diluent QC check that will result in failed QC check, preventing user from testing patient samples for RBC.

Which lots are affected?

Part number 111011, Lot # R1513

Where was it sold?

US Nationwide distribution in the states of IN, WA, NC, CA, GA, CO.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Advanced Instruments

All 2

Other Spinal Implants recalls

All 1,157